↓ Skip to main content

Dove Medical Press

A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
42 Mendeley
Title
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2019
DOI 10.2147/dmso.s199802
Pubmed ID
Authors

CongXiao Zhang, XinWang Zhu, LuLu Li, TianKui Ma, Mai Shi, Ying Yang, QiuLing Fan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 14%
Student > Doctoral Student 4 10%
Student > Bachelor 3 7%
Student > Postgraduate 3 7%
Student > Master 3 7%
Other 6 14%
Unknown 17 40%
Readers by discipline Count As %
Medicine and Dentistry 6 14%
Biochemistry, Genetics and Molecular Biology 4 10%
Veterinary Science and Veterinary Medicine 3 7%
Agricultural and Biological Sciences 3 7%
Immunology and Microbiology 2 5%
Other 5 12%
Unknown 19 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2022.
All research outputs
#3,345,343
of 25,774,185 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#154
of 1,199 outputs
Outputs of similar age
#65,208
of 360,646 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#8
of 46 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,199 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,646 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.